已收盘 07-26 16:00:00 美东时间
+0.100
+9.26%
Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.
06-29 01:59
PTGX: 11% | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3 DJT: 16% | Trump Media & Technology Group shares are trading higher following
06-28 20:37
5 analysts have expressed a variety of opinions on CARISMA Therapeutics (NASDAQ...
06-27 02:01
HC Wainwright & Co. analyst Mitchell Kapoor reiterates CARISMA Therapeutics (NASDAQ:CARM) with a Buy and maintains $8 price target.
06-27 00:22
New Director Brings C-Suite Track Record Driving Growth and Success CARMEL, Ind., June 20, 2024 /PRNewswire/ -- OPENLANE, Inc. (NYSE: KAR), a leading operator of digital marketplaces for who...
06-21 04:15
Carisma Therapeutics (CARM) has shared an announcement. Carisma Therapeutics In...
06-15 05:19
"Absolute Sale" Delivers Increased Velocity, Higher Engagement, Better Results ...
06-04 20:15
PHILADELPHIA, May 30, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and develo...
05-30 19:30
CARMEL, Ind., May 16, 2024 /PRNewswire/ -- Merchants Bancorp ("Merchants") (Nasdaq: MBIN), parent company and registered bank holding company of Merchants Bank of Indiana ("Merchants Bank"),...
05-17 04:05
CARMEL, Ind., May 13, 2024 /PRNewswire/ -- Merchants Bancorp (Nasdaq: MBIN) ("Merchants" or the "Company"), a holding company that operates through its wholly owned banking subsidiary, Merch...
05-14 04:05